Showing results (851-860 of 1,142) with videos related to
Sort By:
Pageof 115
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2022
Cognitive resilience depends on white matter connectivity: The Maastricht StudyNathan R DeJong, Jacobus F A Jansen, Martin P J van Boxtel, et al.Cardiovascular Diabetology|May 4, 2023
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo-The Maastricht StudyElisabetta Rinaldi, Frank Ct van der Heide, Enzo Bonora, et al.Journal of Affective Disorders|July 2, 2022
The cardiometabolic depression subtype and its association with clinical characteristics: The Maastricht StudyAnouk F J Geraets, Miranda T Schram, Jacobus F A Jansen, et al.Circulation|February 1, 2021
Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram DeviceJohn R Giudicessi, Matthew Schram, J Martijn Bos, et al.Journal of Psychosomatic Research|November 22, 2024
Metabolomics profiling of Type D personality traitsRuifang Li-Gao, Mariska Bot, Alexander Kurilshikov, et al.The American Journal of Clinical Nutrition|September 2, 2022
Habitual intake of dietary methylglyoxal is associated with less low-grade inflammation: the Maastricht StudyKim Maasen, Simone J P M Eussen, Pieter C Dagnelie, et al.Journal of Biomedical Informatics|May 28, 2024
Data harmonization and federated learning for multi-cohort dementia research using the OMOP common data model: A Netherlands consortium of dementia cohorts case studyPedro Mateus, Justine Moonen, Magdalena Beran, et al.Diabetologia|November 6, 2025
Liver fat content is not elevated in people with type 1 diabetes: the Maastricht StudyNefeli M Dimitropoulou, Magdalena Beran, Simone J P M Eussen, et al.Discover Electronics|February 4, 2026
Integration and electrical evaluation of WS2 and MoS2 fets in a 300 mm pilot lineT Schram, Q Smets, A Opdebeeck, et al.Diabetes, Obesity & Metabolism|June 19, 2025
Type 2 diabetes and depression via microvascular dysfunction, neurodegeneration, inflammation, advanced glycation end products (AGEs), and arterial stiffnessIndra L M Steens, Miranda T Schram, Alfons J H M Houben, et al.Pageof 115